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Meta-Analysis of Gene-Environment Interaction
Exploiting Gene-Environment Independence
Across Multiple Case-Control Studies
Jason P. Estesa, John D. Ricea, Shi Lib, Heather M. Stringhama, Michael
Boehnkea and Bhramar Mukherjee a,c
Multiple papers have studied the use of gene-environment (G-E) independence to enhance power for testing gene-
environment interaction (GEI) in case-control studies. However, studies that evaluate the role ofG-E independence
in a meta-analysis framework are limited. In this paper, we extend the single-study empirical-Bayes (EB) type
shrinkage estimators proposed by Mukherjee and Chatterjee (2008) to a meta-analysis setting that adjusts for
uncertainty regarding the assumption of G-E independence across studies. We use the retrospective likelihood
framework to derive an adaptive combination of estimators obtained under the constrained model (assuming G-
E independence) and unconstrained model (without assumptions of G-E independence) with weights determined
by measures of G-E association derived from multiple studies. Our simulation studies indicate that this newly
proposed estimator has improved average performance across different simulation scenarios than the standard
alternative of using inverse variance (covariance) weighted estimators that combines study-specific constrained,
unconstrained or EB estimators. The results are illustrated bymeta-analyzing six different studies of type 2 diabetes
(T2D) investigating interactions between genetic markers on the obesity related FTO gene and environmental
factors Body Mass Index (BMI) and age. Copyright c  2016 John Wiley & Sons, Ltd.
Keywords: case-control study; efficiency; empirical Bayes; individual patient data; meta-analysis; type 2
diabetes
1. Introduction
Studies suggest that the risks of many complex diseases depend on the combined effects of genetic susceptibility factors
G and environmental exposures E. Studies of G-E interactions (GEI), particularly for rare exposures, require large
sample sizes and efficient designs. Exploiting independence between the genetic and environmental factors in case-control
studies to gain efficiency has been noted by several authors [1, 2, 3]. In particular, [3] studied the semi-parametric
maximum likelihood estimates of logistic regression parameters that exploit the G-E independence assumption in a
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general regression setting that may involve continuous exposures, non-rare diseases and other stratification variables.
While [3] alleviates many of the limitations of prior work, retrospective methods that assume G-E independence have the
potential to yield severely biased estimates and inflated type 1 errors when the assumption is violated. Several studies have
addressed this issue and proposed more robust strategies for testing GEI [4, 5, 6, 7]. For example, using the retrospective
likelihood framework in [3], Mukherjee and Chatterjee [4] proposed an adaptive estimator that does not impose the
independence assumption exactly and allows for uncertainty in the assumption of gene-environment independence. The
G-E log-odds ratio parameter is estimated in an empirical Bayes (EB) fashion to arrive at a final shrinkage estimator that
’shrinks’ the semi-parametric retrospective maximum likelihood estimates under G-E dependence to those under G-E
independence to trade off between bias and efficiency.
Detecting gene-environment interactions with small effect sizes will often require a meta-analytic approach. There are
several methods of meta-analyzing a single scalar gene-environment interaction effect across studies. For example, one can
use an inverse-variance weighted fixed-effect approach for the GEI parameter [8, 9, 10] when individual patient data are
not available. To meta-analyze a parameter vector, one can use an inverse variance-covariance weighted estimator [11, 12].
Alternatively, when individual patient-level data from all studies are available, the data can be analyzed simultaneously,
commonly called joint analysis or mega-analysis. Furthermore, [10, 11] showed that meta-analysis based on summary
statistics has the same asymptotic efficiency as the MLE resulting from the full data if the former analysis is performed
jointly on all common parameters across studies. One can easily incorporate the work of Mukherjee and Chatterjee [4]
into the meta-analysis framework by using the aforementioned inverse-variance or inverse variance-covariance approach
with study specific EB estimators; however such an approach does not directly borrow information across studies with
respect to the uncertainty around the G-E independence assumption.
To date, there are no papers that study the role of G-E independence in a meta-analysis framework where uncertainty
in the assumption can vary across studies. In this work, we consider several multiple-study empirical Bayes (MSEB) type
shrinkage estimators that extend the EB type shrinkage estimators proposed in [4] to a multiple-study setting that can
borrow information across studies. Furthermore, our MSEB estimators can be readily constructed using existing software
such as CGEN [13], making our proposed estimators easily implementable. We propose MSEB estimators in cases where
(i) individual patient data (IPD) are available and (ii) only study level summary statistics are available.
Our paper is organized as follows. We introduce the proposed MSEB estimators in Section 2.2, and simulation studies
are carried out in Section 3. In Section 4, we illustrate our methods by meta analysis of G-E interactions of SNPs on
FTO gene with BMI and age using data from six different studies of type 2 diabetes. Concluding remarks are presented in
Section 5.
2. Proposed Multiple Study Empirical Bayes Type Shrinkage Estimators
2.1. Model Specification
Let D = 1 (D = 0) denote the presence (absence) of a disease, G denote a genetic factor, E denote an environmental
exposure and S denote a vector of covariates. The subscript k = 1, . . . ,K is used to index K independent studies and the
subscript i = 1, . . . , nk is used to index individuals within the kth study of size nk. Consider the following factorization
of the retrospective likelihood akin to [3],
LR =
KY
k=1
nkY
i=1
pr(Gki, Eki, Ski|Dki)
=
KY
k=1
nkY
i=1
pr(Dki|Gki, Eki, Ski)pr(Gki|Eki, Ski)pr(Eki, Ski)P
G,E,S pr(Dki|G,E, S)pr(G|E,S)pr(E,S)
. (1)
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For continuous exposureE, the sum with respect toE in the denominator of (1) is replaced by an integral. The components
of the retrospective likelihood are modeled as follows. Assume a logistic disease incidence model
pr(Dki|Gki, Eki, Ski) = H{ 0k +m(Gki, Eki,Ski; )} (2)
whereH(u) = {1 + exp( u)} 1,m(·) is a known but arbitrary function,  0k are intercept parameters and   is a vector of
parameters of interest. In this model specification, the intercept is allowed to vary with respect to the K studies whereas
the parameter vector,  , of log odds ratios associated with G,E and S is shared among the studies. For a dominant
susceptibility model of G, we consider a logistic model
pr(Gki = 1|Eki,Ski) = H{⌘0k + ⌘kSki + ✓kEki}, (3)
where ✓k are study level nuisance parameters that measure dependence between G and E within the k-th study, ⌘0k are
intercept parameters and ⌘k are study-specific row vectors of parameters corresponding to individual covariates. Under
the assumption of G-E independence (conditional on S) within each study k, the parameters ✓k are all set to 0, and model
(3) reduces to
pr(Gki = 1|Eki,Ski) = H{⌘00k + ⌘0kSki}. (4)
For an additive susceptibility model ofG, one might consider a proportional odds model for pr(G|E,S). For a co-dominant
susceptibility model of G, one might consider polychotomous logistic regression. In (3), one can alternatively model
these probabilties under Hardy-Weinberg equilibrium [14] (see the Supporting Information). Finally, the joint distribution
function for (E,S) is allowed to remain completely nonparametric [3].
The aforementioned model formulation is quite flexible in allowing parameters to depend on k. For example, one may
assume a commonG-S association across studies in model (3), i.e. ⌘k = ⌘ for k = 1, ...,K and some constant ⌘. Similarly,
one may require ✓k = ✓ for k = 1, ...,K. We proceed with the most general formulation (⌘k, ✓k) in model (3), but assume
a shared common effect   among the K studies in model (2). Different choices are investigated in our data application.
2.2. MSEB Shrinkage Estimators
In this section, we extend the EB shrinkage estimator proposed in [4] to an appropriate multi-study empirical Bayes
(MSEB) estimator. In Section 2.2.1, we detail our proposed estimators under the assumption that individual patient data
(IPD) are available for each study, and in Section 2.2.2, we detail our proposed estimators using summary (aggregate) data
from each of the K studies.
When one is not certain about the G-E independence across the k studies, one may conceptually posit a stochastic
framework for the underlying true parameters ✓ = (✓1, . . . , ✓K) ⇠MVN(0,A) where 0 is a K ⇥ 1 vector of zeros and
A is a K ⇥K diagonal matrix whose nonzero elements are all equal to some non-negative constant ⌧2 which reflects a
measure of uncertainty about the independence assumption. This is the stochastic framework governing the methods we
present subsequently.
2.2.1. IPD analysis Let   = ( 0, ,⌘0,⌘)T denote the focus parameters of the unconstrained model (3) where  0 =
( 01, . . . ,  0K)T, ⌘0 = (⌘01, . . . , ⌘0K)T, ⌘ = (⌘1, . . . ,⌘K)T and   represents a parameter vector shared among the K
studies. A superscript of zero will be used to denote the corresponding parameters under the constrained model (4) e.g.
 0 = ( 00 , 
0,⌘00 ,⌘
0)T. The MLEs (b , b✓) and b  0 for ( ,✓) and  0 are obtained, along with their estimated asymptotic
variances bV(b ,b✓) and bVb  0 , using the profile-likelihood techniques of [3] respectively. Intuitively, given ✓, and in the
absence of any prior information on  , a natural way to estimate   is to use b (✓), the profile MLE of   for a fixed
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✓. Define  (✓) to be the limiting value of b (✓), which is a population parameter when ✓ is fixed at the true value. The
estimate b (0) denotes the profile MLE of   under the constrained model when ✓ = 0. The goal is to obtain an estimator of
 (✓), the common set of parameters in the disease incidence model shared among theK studies, that takes into account the
uncertainty about the G-E independence assumption on ✓, which may vary across studies. Thus, we developed weighted
estimators of  (✓) whose weights shrink the estimates of  (✓) towards b (0) when there is less uncertainty regardingG-E
independence.
To achieve the goal of developing our MSEB estimators of  (✓), we first approximate the distributions of  (✓) and
 (b✓) using the prior distribution ✓ ⇠MVN(0,A). A first order Taylor’s expansion of  (✓) about ✓ = 0 gives
 (✓) ⇡  (0) + T✓ (5)
where  T ⌘ @ T(✓)/@✓ |✓=0 is the gradient matrix evaluated at ✓ = 0. Thus, we can approximate the distribution
of  (✓) via MVN( (0), TA ). Finally, we approximate the distribution of  (b✓) via its asymptotic distribution
MVN{ (✓),V (b✓)} leading to the Bayes estimate of  (✓) as the posterior mean
 TA {V (b✓) + TA } 1 (b✓) + V (b✓){V (b✓) + TA } 1 (0) (6)
of  (✓) |  (b✓) under our Gaussian-Gaussian model. Our Bayes estimate of   is taken to be the corresponding sub-
vector of our Bayes estimate of  (✓). The components of the weights in (6) are estimated as follows. Replace  (b✓)
and  (0) with b (b✓) and b (0) respectively, and replace V (b✓) with the corresponding sub-matrix of bV(b ,b✓). From the
Taylor’s approximation in (5), we approximate { (✓)   (0)}✓T via  T✓✓T. The matrix ✓✓T is not invertible when
K > 1, so we use its Moore-Penrose inverse (✓✓T)+ leading to the use of  T(✓✓T)(✓✓T)+ as an approximation to
{ (✓)   (0)}✓T(✓✓T)+. In general, (✓✓T)(✓✓T)+ is not equal to the identity matrix IK of dimension K ⇥K, so we
replace it with its expectation. The matrix (✓✓T)(✓✓T)+ has expectation K 1IK and variance (K 1  K 2)IK , yielding
our final approximation K{ (✓)   (0)}✓T(✓✓T)+ of  T (see Theorem 1 in the Supporting Information). Since  (✓),
 (0) and ✓ are unknown, we replace them with their estimates. We consider four different estimates of A = ⌧2IK . If
estimators (ii) - (iv) result in a negative value, we take b⌧ 2 to be zero (the well-known positive part estimator) [15]. The
estimator presented in (i) below will be serve as the primary estimator of A throughout the paper, whereas estimators (ii)
- (iv) are presented as alternative natural approaches that other practitioners may think of.
(i) Our first estimateK 1(b✓Tb✓) of ⌧2 is conservative and motivated by the asymptotic distribution of b✓ | ✓marginalized
over ✓, to wit, N(0,A+ Vb✓).
(ii) Our second estimate K 1{b✓Tb✓   tr( bVb✓)} of ⌧2 adjusts for the conservative nature of our first estimate.
(iii) Our third estimate of ⌧2 is motivated by maximizing the log marginal likelihood obtained from the multivariate
density N(0,A+ Vb✓) with respect to ⌧2 given Vb✓ = bVb✓. Let {bv1, . . . ,bvK} denote the diagonal elements of bVb✓. We
maximize the marginal likelihood
L(⌧2 | b✓,Vb✓ = bVb✓) = KY
k=1
 
2⇡(⌧2 + bvk)   12 expn  b✓ 2k
2(⌧2 + bvk)
o
(7)
with respect to ⌧2 by setting the derivative
d
d⌧2
h
log
 L(⌧2 | b✓,Vb✓ = bVb✓) i =  12
KX
k=1
(
1
⌧2 + bvk   b✓ 2k(⌧2 + bvk)2
)
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equal to 0. We implement the uniroot function in R to numerically approximate b⌧ 2.
(iv) Our fourth estimate of ⌧2 results from an iterative process proposed in [16, 17], extending our second estimate by
considering weights (other than K 1) that depend on variances as follows. The update of b⌧2(n) at iteration n+ 1 is
given by
b⌧2(n+1) = ⇢ KX
k=1
wk,(n)
  1 KX
k=1
wk,(n)
 b✓ 2k   bvk , (8)
where wk,(n) = {bvk + b⌧2(n)} 1, and the initial guess ⌧2(0) is the estimate resulting from the maximization of the
marginal likelihood in (7). Our estimate of ⌧2 is taken to be ⌧2(m) where m 2 N is some iteration step (greater than
zero) such that |⌧2(m+1)   ⌧2(m)| < ✏ where ✏ is some positive tolerance value which we take to be 10 8.
We denote our empirical Bayes estimates of   resulting from the four proposed estimators (i), (ii), (iii) and (iv) of A byb EB1, b EB2, b EB3 and b EB4 respectively. We note in the case that b⌧ 2 is estimated to be zero, (6) reduces to  (0) which
is estimated via CML. This property affects estimators b EB2   b EB4, but does not affect b EB1 (with probability 1) due
to the conservative nature of (i). We refer the reader to variance approximations of these estimators in the Supporting
Information. The operating characteristics of our estimators are evaluated via simulation study in Section 3.
2.2.2. Meta-Analysis Using Summary Measures In the absence of individual level data, we consider a meta-analytic
approach using effect and variance estimates. Within each study, we denote the MLEs of  k = ( 0k, k, ⌘0k,⌘k)T and ✓k
under the unconstrained model by e k = (e 0k, e k, e⌘0k, e⌘k)T and e✓k respectively, and the MLEs of  0k = ( 00k, 0k , ⌘00k,⌘0k)T
under the constrained model by e  0k = (e  00k, e  0k , e⌘ 00 , e⌘ 0k )T. We use Ve↵ to denote the covariance matrix of a generic
parameter estimate e↵, and eVe↵ will be used to denote its covariance estimate. Intuitively, given ✓k, and in the absence
of any prior information on  k, a natural way to estimate  k is to use e k(✓k), the profile MLE of  k for a fixed ✓k. In
order to combine the information of the K studies, we consider the inverse variance-covariance meta-analysis estimates
of the common focus parameters   and  0 given by
e  =  Pk eV  1e k   1Pk eV  1e k e k and e  0 =  Pk eV  1 ˜ 0k   1Pk eV  1e  0k e  0k
with variance estimates
 P
k
eV  1e k   1 and  Pk eV  1e  0k   1 respectively. These meta-analysis estimators can be viewed as
functions of ✓ since  k are estimated using the profile MLEs e k(✓k) for a fixed ✓k. Thus, e  ⌘ e (e✓) and e  0 ⌘ e  0(0) can
be viewed as estimates of  (e✓) and  (0) respectively.
Similar to Section 2.2.1, we use the prior distribution ✓ ⇠MVN(0,A) and a first order Taylor’s expansion  (✓) ⇡
 (0) + T✓, where  T ⌘ @ T(✓)/@✓ |✓=0, to approximate the distributions of  (✓) and  (e✓) viaMVN{ (0), TA }
andMVN{ (✓), V (e✓)} respectively. Our empirical Bayes estimate of  (✓) is taken to be the posterior mean
 TA {V (e✓) + TA } 1 (e✓) + V (e✓){V (e✓) + TA } 1 (0) (9)
of  (✓) |  (e✓) under our Gaussian-Gaussian model. The components of the weights in (9) are estimated as follows.
Replace  (e✓),  (0), V (e✓) and  T with e , e 0,  Pk eV  1e k   1 and K{e (✓)  e (0)}✓T(✓✓T)+ (see Section 2.2.1)
respectively. Finally, we consider four different estimates of A as defined in Section 2.2.1 except that the estimates in
the expressions are not the result of IPD but the result of meta-analysis of the K independent studies (hats are replaced
with tildes). We denote these estimators by e EB1, e EB2, e EB3 and e EB4 respectively. For convenience, we may refer to these
estimators via EB1, EB2, EB3 and EB4 respectively (IPD joint analysis vs. summary statistic meta-analysis will be clear
from context). Alternatively, one can use the inverse variance-covariance meta-analysis estimates of the focus parameters
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resulting from single study empirical Bayes estimation e.g.
e EB =  X
k
eV  1e EBk   1X
k
eV  1e EBk e EBk
where e EBk and eVe EBk are defined as in [4]. For convenience, we may refer to this estimator as EB (IPD joint analysis vs.
summary statistic meta-analysis will be clear from context). The operating characteristics of our estimators are evaluated
and compared to other sensible estimators via simulation study in Section 3.
3. Simulation Study
We carry out simulation studies to study the performance of our proposed MSEB estimators (EB1 - EB4) in
the IPD and meta-analysis settings relative to the standard inverse variance-covariance weighted logistic regression
(LOG), unconstrained maximum likelihood (UML), constrained maximum likelihood (CML), and empirical Bayes (EB)
using the statistical R package CGEN. The operating characteristics of interest are bias, average estimated standard
error, empirical standard error, and mean squared error with estimates defined by R 1
PR
r=1(⇠ˆr   ⇠), R 1
PR
r=1
bV⇠ˆr ,
{(R  1) 1PRr=1(⇠ˆr   ⇠r)2}1/2 and R 1PRr=1(⇠ˆr   ⇠)2 where ⇠ is the parameter of interest, b⇠r is its estimate, ⇠r =
R 1
PR
r=1 ⇠ˆr and bV⇠ˆr is the variance estimate of b⇠r in the r = 1, . . . , R study replications. In our simulation studies, we
set R equal to 1000.
The components of the model defined in (2) and (3) are as follows. The subscript i = 1, . . . , nk is used to index
subjects, and k = 1, . . . ,K is used to index K = 10 subcohorts with sample sizes nk = 1000 + 100(k   1) yielding
a total of n =
P10
k=1 nk = 14500 subjects. We considered the stratification vector Ski = (S1ki, S2ki) where S1ki is
a Bernoulli random variable with parameter .5, and S2ki is a normal random variable with mean 0 and standard
deviation .5. Environmental exposures were generated via Eki = min{5, exp(Xki)} where Xki|S1ki = 0 ⇠ N(0, .52) and
Xki|S1ki = 1 ⇠ N(.1, .52). Conditional on (Eki,Ski), a genetic factor (under HWE) was generated via a multinomial
random variable with parameters (1  qki)2, 2qki(1  qki) and q2ki defined by qki = H{⌘0k + ⌘kSki + ✓kEki}, where
⌘0k
iid⇠ Uniform( 1.2, 1.0), ⌘k = (⌘1k, ⌘2k), ⌘1k iid⇠ Uniform(0.1, 0.2), ⌘2k iid⇠ Uniform(0, 0.1) and ✓k is generated as
follows (i) ✓k = 0 for all k, (ii) ✓k = .1 for all k, (iii) ✓k =  .5 for all k, (iv) ✓k iid⇠ N(.2, .12) and (v) ✓k iid⇠ Unif( .2, .2).
Binary disease outcomeDki for subject i belonging to the kth study was generated from a Bernoulli random variable with
rate parameter defined by H{ 0k +  GGki +  EEki +  GEGkiEki +  SSki}. We constructed our case-control sample
by randomly selecting nk/2 cases and nk/2 controls within the kth subpopulation from the generated population data
{(Dki, Gki, Eki,Ski) : i = 1, . . . , Nk; k = 1, . . . ,K} withNk = 200nk. In our simulation setup, the prevalence of disease
was approximately 4% and the minor allele frequency was approximately 26% within our K subpopulations. In this
section, IPD will refer to combining the generated data for a joint analysis which uses the retrospective likelihood defined
in (1).
3.1. Simulation Results
The simulation results are summarized in terms of bias, standard error, empirical standard error and mean squared error
under G-E independence (Table 1) and G-E dependence (Tables 2 and 3). For convenience, we multiplied all estimated
MSE values by 100, and will refer to these scaled values as MSE. In addition, we restrict our attention only to the GxE
interaction effect estimate. Under G-E independence, each of the estimators have an estimated bias close to zero (within
.000 - .004) in both the IPD and meta-analysis settings. Additionally, the CML estimator has the smallest mean squared
error (.030 and .029) in comparison to the other estimators (.039 - .080) in both the IPD and meta-analysis settings
respectively. Under G-E independence, the proposed estimators EB2, EB3 and EB4 perform similarly to the empirical
Bayes (EB) estimator with respect to MSE (IPD: .049 vs. .051 or .052) under the IPD setting, whereas the proposed
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estimator EB1 does not. This is explained by the fact that ⌧2 is overestimated in EB1 and the other estimators EB2, EB3
and EB4 reduce to the CML estimator when ⌧2 is estimated to be 0, which happened in approximately 8% of the Monte
Carlo runs. Similar findings are observed (Table 1) in the meta-analysis setting. A contributing factor to these findings,
similar to IPD, is that EB2, EB3 and EB4 yielded exactly the same estimates as CML in various individual study analysis.
Thus, in both IPD and meta-analysis, EB1 tends to have higher MSE than EB2 - EB4 underG-E independence since EB2 -
EB4 have the ability to reduce to CML, the most efficient estimator of all estimators considered underG-E independence.
In Table 2, we consider modest and strong departure from G-E independence by fixing ✓k at .1 and -.5 for all k. In both
cases, the CML estimator is severely biased (IPD: .065 and -.331; Meta: .065 and -.329) and has the largest MSE (IPD:
.449 and 11.034; Meta: .450 and 10.858). In both scenarios, our estimators EB1 - EB4 outperform CML and EB with
respect to bias (IPD: .002 - .007 vs. -.331 - .003; Meta: .000 - .009 vs. -.329 - .065) and MSE (IPD: .065 - .115 vs. .101
- 11.034; Meta: .063 - .114 vs. .216 - 10.858). Simulation studies fixing ✓k at a constant c for all k (not reported) suggest
that even minor departures from zero, e.g. c = .05, can produce inflated type I error and severe bias.
In Table 3, we consider modest and mild departure from G-E independence by specifying the distributions of ✓k to be
independently normal with mean and standard deviation .2 and .1 respectively, or independently uniform with parameters
-.2 and .2 for all k. In the case of mild, and approximately symmetric departure from GxE independence (about zero),
our MSEB estimators perform similarly to the EB estimator, which has the smallest MSE (.063 - .064 vs. .059), in the
IPD setting. In the meta-analysis setting, our MSEB estimators have the smallest MSE (.061 - .062) among all estimators
considered. In the case of modest departure under a normal distribution on ✓ with nonzero mean, our MSEB estimators
perform almost identically to the UML estimator with respect to MSE (IPD: .060 vs. .059; Meta: .059 vs. .059) which
has the smallest MSE in both the IPD and meta-analysis settings. Most notably, our MSEB estimators outperform the EB
estimators with respect to MSE in both meta-analysis settings considered (.059 - .062 vs. .077 and .218). A contributing
factor to these results is that the inverse variance-covariance weighted EB estimator does not necessarily produce an
estimator that lies between the inverse variance-covariance weighted constrained maximum likelihood estimator and the
inverse variance-covariance weighted unconstrained maximum likelihood estimator. For example, in our simulation runs,
the EB estimator fell in between the UML and CML estimators in only 473 of the 1000 Monte Carlo runs under G-E
independence. Further simulation (not reported) considered normal distributions with location parameters further from
zero, e.g. -.5 and .5. In these settings we found the MSEB estimators to perform nearly identical to the UML estimator
with respect to MSE in both the IPD and meta-analysis setting.
These simulation results indicate the data-adaptive feature of MSEB estimators across varying simulation scenarios.
Although they do not outperform other options considered in some of the simulation scenarios, they do offer protection
against bias and inflated MSE across all simulation scenarios investigated should GxE independence be incorrectly
assumed. Further simulation studies with individual study sample sizes nk (100 to 300 subjects), number of individual
studies K (2 and 5), MAF (5% and 10%), marginal disease prevalence (10% and 20%) and case-control ratios (1:2
and 1:4) are presented in the Supporting Information (Tables S1 - S16). The results of these additional simulation
studies are consistent with the findings noted in our simulation setup described above. More specifically, adjustments
in individual study sample sizes, number of individual studies, MAF and case-control ratios resulted in different (from
our main simulation setup) magnitudes of bias, standard error and mean squared error, but relative performance of the
methods did not notably change. Similar findings resulted when the marginal disease prevalence was increased to 10%, but
when increased to 20%, CML was generally biased and inefficient; however, our MSEB estimators still offered excellent
protection against bias and loss of efficiency.
4. Analysis of Type 2 Diabetes Data
A number of SNPs in the fat mass associated FTO gene (region 16q12.2) have previously been found to be associated
with T2D and BMI [18, 19, 20]. BMI with a strong genetic heritability, also has environmental contribution so it is likely
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that the assumption of G-E independence is violated between SNPs on the FTO gene and BMI. In our data analysis, we
apply our proposed methods to estimate the interaction effects between SNPs (rs11642841, rs6499640 and rs1121980) in
the FTO gene and environmental factors (age and BMI) on T2D using case-control studies that are a part of FIN-D2D
2007 (D2D2007), The DIAbetes GENetic Study (DIAGEN), the Finland-United States Investigation of NIDDM Genetics
Stage 2 (FUSION S2), The Nord-Trøndelag Health Study 2 (HUNT), the METabolic Syndrome In Men Study (METSIM)
and the Tromsø Study (TROMSO) [18]. There are a total of N = 9616 individuals, comprised of 4418 cases and 5198
controls. Sample sizes within each study varied from 1058 to 2215 and the case to control ratio within each study varied
from .37 to 1.75 with an overall case to control ratio of .85. Descriptive summary statistics from the six studies are shown
in Table 4. Individuals in the case group were significantly older (62.2 v.s. 59.0, P-value<0.001), had significantly higher
BMI (30.1 v.s. 26.4, P-value<0.001) and had a significantly lower percentage of females (34% v.s. 45%, P-value<0.001)
than individuals in the control group. The minor allele frequency of SNPs rs11642841, rs6499640 and rs1121980 across
the six studies range from .40 to .45, .37 to .42 and .40 to .49 respectively, and the coefficients of linkage disequilibrium are
r2 = .24 (rs11642841 and rs6499640), r2 = .48 (rs11642841 and rs1121980) and r2 = .09 (rs6499640 and rs1121980).
The six different studies were treated as independent contributors to the IPD/meta-analysis. We applied our proposed
MSEB estimators using several variants of the model specified in Section 2.1 for the following (observed) three scenarios:
(1) weak G-E (age and rs11642841) association (trend test p-value in Table 4 among controls: 3.6⇥ 10 1) supporting
G-E independence; (2) strong G-E (BMI and rs6499640) association (trend test p-value in Table 4 among controls:
3.3⇥ 10 3); and (3) modest G-E (BMI and rs1121980) association (trend test p-value in Table 4 among controls:
3.0⇥ 10 2), which are reflected in the (conditional) G-E association in the control group across the six studies (Table
4). The outcome variable D in each scenario indicates the presence/absence of T2D, and the variable G (coded 0,1,2)
represents the particular SNP specified in each scenario. In scenario (1), the exposure variable E denotes age and we used
the stratification variable S = (S1, S2) where S1 is BMI and S2 is gender. In scenarios (2) and (3), the exposure variable
E denotes BMI and we used the stratification variable S = (S1, S2) where S1 is age and S2 is gender. In particular, the
standard logistic regression model was specified as
log
n
P (Dki=1|Eki,Gki,Ski)
P (Di=0|Ei,Gi,Ski)
o
=  0k +  1Eki +  2Gki +  3GkiEki +  4Ski1 +  5Si2 (10)
in the IPD joint-analysis and specified as
log
n
P (Dki=1|Eki,Gki,Ski)
P (Di=0|Ei,Gi,Ski)
o
=  0k +  1kEki +  2kGki +  3kGkiEki +  4kSki1 +  5kSi2 (11)
in the meta-analysis whereD denotes T2D disease status, G (coded 0,1,2) corresponds to rs11642841 (SNP1), rs6499640
(SNP2) or rs1121980 (SNP3),E corresponds to age (BMI) whenG corresponds to SNP1 (SNP2 or SNP3), S1 corresponds
to BMI (age) when E corresponds to age (BMI), S2 indicates male sex, i indexes subjects and k indexes studies. For
the UML, CML, EB and our proposed MSEB estimators, we further model the minor allele frequency using a logistic
regression model with covariates E and S under HWE similar to Section 2.1.
Meta-Analysis: Table 5 displays the GxE interaction effect estimates resulting from a standard inverse variance
weighted univariate meta-analysis and our proposed MSEB estimators in the meta-analysis setting. As expected, an
interaction effect was not detected in scenarios (1) and (3), and was detected in scenario (2). In our data results, our
MSEB estimators tend to have smaller standard error than the standard logistic regression approach and unconstrained
maximum likelihood approach. In addition, we point out that our proposed estimators EB2, EB3 and EB4 reduce to the
constrained maximum likelihood estimates in the case that the uncertainty parameter ⌧2 is estimated to be 0 as was the
case in scenarios (1) and (3).
To evaluate the G-E independence assumption, we estimate the association parameter of G (rs6499640) with BMI
among controls across the six case-control data sets sampled from D2D2007 (1), DIAGEN (2), FUSION S2 (3), HUNT
(4), METSIM (5) and TROMSO (6) adjusting for age and sex using a standard multivariate regression model. In Figure
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1, we report these estimated association parameters -0.38 (-.72, -.04), -0.15 (-.65, .34), -0.37 (-.68, -.06), -0.21 (-.62, .20),
0.01 (-.32, .35) and -0.04 (-.46, .38) for the six individual studies respectively. While the figure may suggest evidence
against G-E independence, we draw attention to the differences in the confidence intervals with respect to the point
estimates and widths which reflects varying uncertainty in the G-E independence assumption.
IPD: In Table 6, we display the results for scenarios (1) - (3) using our proposed MSEB estimators in the following
variants of the model specified in Section 2.1: (1) ✓k = ✓ for all k and ⌘k is allowed to vary across each study (2)
both ✓k and ⌘k are allowed to vary across studies (3) ✓k = ✓ and ⌘k = ⌘ for all k and (4) ✓k is allowed to vary across
studies while ⌘k = ⌘ for all k. The estimates and standard errors are similar in each scenario, however, there is generally
precision gain in comparison to the standard logistic regression, and comparable results to the MSEB estimators in the
meta-analysis setting (Table 4). In particular, we make the following two key observations: (1) in the estimation of the
age⇥rs11642841 (weak G-E association) interaction effect, all the methods provide very close estimates and improved
precision over the standard logistic or unconditional approach and (2) in the estimation of the BMI⇥rs1121980 and
BMI⇥rs6499640 interactions effects, the constrained model estimates differed substantially from the estimates resulting
from the unconstrained model. As expected, our MSEB estimates tend towards the constrained model estimates when the
G-E association is weak and tend towards the unconstrained estimate when the G-E association is strong.
In Figure 2 we present stratified odds ratios associated with a five-unit change (one interquartile change) in BMI across
the three genotype subgroups after adjusting for age, sex and study cohort. The marginal OR is 2.57, 95% CI (2.43, 2.72).
When stratified by genotype status the homozygous major allele G = 0 group had OR of 2.34, 95% CI (2.16, 2.55) while
the homozygous minor allele sub-group had an OR of 2.95 (2.64, 3.31). The P-value for testing interaction was 0.005.
This finding needs follow up and replication in future studies. In Li et al. [12], we noticed a significant BMI⇥rs1121980
interaction effect with HDL cholesterol level as outcome.
5. Discussion
In this paper, we extended the single-study empirical-Bayes (EB) type shrinkage estimators proposed by Mukherjee and
Chatterjee (2008) to a meta-analysis setting that adjusts for uncertainty in the assumption of G-E independence. We used
the retrospective likelihood framework to derive an adaptive combination of estimators obtained under the constrained
model (assuming G-E independence) and unconstrained model (without any assumptions of independence) with weights
determined by measures ofG-E association derived frommultiple studies. Our simulation studies indicate that these newly
proposed MSEB estimators have smaller mean squared error (MSE) than the standard alternative of using constrained,
unconstrained or EB estimators in the meta-analysis summary statistic setting when the G-E independence assumption
is moderately violated. As previously noted, a contributor to these results is that the standard inverse variance-covariance
weighted EB estimates do not necessarily lie between the standard inverse variance-covariance weighted UML and
CML estimates (weight contamination). We also note that in other simulation settings the CML and EB can sometimes
offer better performance than the newly proposed MSEB estimators. However, in terms of average performance across
different scenarios of uncertainty regarding the G-E independence assumption, the newly proposed MSEB estimators
offers protection in terms of bias without sacrificing much efficiency.
In the face of uncertainty, when historic data nor biology have established G-E independence, our recommendation
is that the EB estimator be used in the IPD setting and our proposed MSEB estimators be used in the meta-analysis
setting when individual patient data are not available. Specifically, we point to our MSEB estimator EB1 as the estimator
of choice (in the meta-analysis setting) for the following various reasons. 1.) EB1 is easy to implement and does not
require an iterative process in the estimation of the covariance matrix A (required in EB3 and EB4); 2.) EB1 does not
have the inherent problem (with probability 1) of yielding estimates identical to CML as does EB2 - EB4 (when b⌧ 2
is estimated to be 0) which deteriorates their ability to protect against bias and loss of efficiency when the assumption
of G-E independence is false; 3.) EB1 has smaller mean squared error relative to standard logistic regression (LOG)
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and the unconstrained maximum likelihood (UML) estimator when G-E independence holds; 4.) EB1 offers protection
against inflated bias and MSE when G-E independence does not hold; 5.) The derived variance approximation formula
(Supporting Information) for EB1 is simpler, easier to implement and more stable than the derived variance approximation
formulas for EB2 - EB4. While our simulation studies support the use of our variance approximations, it is important to
note that the variance approximations for EB2, EB3 and EB4 depend on (b✓Tb✓) 2, which can become very large if ✓k
is estimated too close to 0 for all k. This can make these approximations unstable. A caveat of our proposed method is
the additional modeling of the conditional mean of G given E. Various forms of model misspecification in the profile
likelihood approach of [3] have been considered in literature, e.g., [21, 22]. Misspecification of either P (D | G,E) or
P (G | E) can lead to bias. Model misspecification and measurement error are ubiquitous in the G⇥ E literature and also
remain a concern in our approach.
We applied our methods to six different case-control data sets sampled from D2D2007, DIAGEN, FUSION S2, HUNT,
METSIM and TROMSO. Our MSEB estimators reported sensible results relative to other considered estimates (e.g.
standard logistic regression, unconstrained maximum likelihood and constrained maximum likelihood) and suggest that
there is evidence to support SNP⇥BMI effects (rs6499640 and rs1121980) on T2D.We provide R codes for the simulation
study at https://github.com/jpestes/mseb/blob/master/sim.txt.
Typically, individual patient data are not available to researchers for systematic review. Summary data provides a nice
alternative avenue for analysis; however, it may be challenging to obtain the full covariance matrix from the researchers
responsible for each individual study since only the diagonal elements are typically published. Nevertheless, increasing
communication and advancements in technology among researchers can alleviate these issues.
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Figure 1. Estimated association parameter of G (rs6499640) with BMI among controls across the six case-control data sets sampled from D2D2007 (1), DIAGEN (2), FUSION
S2 (3), HUNT (4), METSIM (5) and TROMSO (6) adjusting for age and sex using a standard multivariate regression model.
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Figure 2. Estimated disease (T2D) odds ratios among subjects with genotype measured for the SNP rs6499640 (coded 0,1 or 2) located on the FTO gene associated with a five-unit
increase (interquartile range) in exposure (BMI) adjusting for age, sex and study cohort resulting from IPD joint analysis using standard logistic regression. Estimated marginal
odds ratio for BMI without adjusting for genotype is also provided and labeled ‘Overall’.
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Table 1. Bias (BIAS), standard errors (SE1), empirical standard errors (SE2) and 100⇥MSE (MSE) of b E , b G and b GE
resulting from standard logistic regression (LOG), unconstrained maximum likelihood (UML), constrained maximum
likelihood (CML), empirical Bayes (EB) and our proposed multi-study empirical Bayes estimators EB1 - EB4 in both
IPD and summary statistic meta-analysis (META) simulation settings under G-E independence over 1,000 Monte Carlo
runs. In the meta-analysis setting, we use the inverse variance-covariance weighted approach to obtain the standard logistic,
unconstrained, constrained and empirical Bayes results.
Main Effect of E Main Effect of G GxE Interaction
IPD BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .011 .0235 .0236 .067 .007 .0263 .0269 .077 .004 .0271 .0279 .080
UML .012 .0233 .0233 .068 .006 .0261 .0268 .075 .002 .0263 .0268 .072
CML .015 .0207 .0207 .064 .006 .0260 .0267 .074 -.004 .0163 .0169 .030
EB .013 .0214 .0213 .063 .006 .0260 .0267 .074 .001 .0218 .0221 .049
EB1 .012 .0231 .0229 .067 .006 .0261 .0268 .075 .002 .0256 .0257 .066
EB2 .013 .0231 .0222 .066 .006 .0261 .0267 .075 .000 .0237 .0227 .051
EB3 .013 .0216 .0223 .067 .006 .0261 .0267 .075 .000 .0200 .0228 .052
EB4 .013 .0216 .0222 .066 .006 .0261 .0267 .075 .000 .0200 .0227 .052
META BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .010 .0236 .0235 .065 .005 .0263 .0268 .074 .002 .0272 .0276 .076
UML .011 .0233 .0232 .066 .005 .0261 .0267 .074 .001 .0263 .0267 .071
CML .014 .0207 .0206 .062 .005 .0261 .0266 .074 -.003 .0164 .0168 .029
EB .014 .0211 .0208 .062 .005 .0261 .0266 .073 -.002 .0203 .0197 .039
EB1 .012 .0231 .0228 .065 .005 .0261 .0267 .074 .000 .0254 .0253 .064
EB2 .013 .0219 .0217 .063 .006 .0261 .0267 .074 -.001 .0206 .0211 .045
EB3 .013 .0218 .0218 .064 .005 .0261 .0266 .074 -.001 .0203 .0212 .045
EB4 .013 .0218 .0217 .063 .005 .0261 .0267 .074 -.001 .0203 .0212 .045
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Table 2. Bias (BIAS), estimated standard errors (SE1), empirical standard errors (SE2) and 100⇥MSE (MSE) of b E ,b G and b GE resulting from standard logistic regression, unconstrained maximum likelihood, constrained maximum
likelihood, empirical Bayes and our proposed multi-study empirical Bayes estimators in both IPD and summary statistic
meta-analysis (META) simulation settings when G-E independence is violated. In the meta-analysis setting, we use the
inverse variance-covariance weighted approach to obtain the standard logistic, unconstrained, constrained and empirical
Bayes results.
✓k = .1 for all k Main Effect of E Main Effect of G GxE Interaction
IPD BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .012 .0251 .0249 .077 .007 .0257 .0253 .069 .006 .0262 .0260 .072
UML .014 .0247 .0244 .078 .006 .0255 .0251 .066 .004 .0253 .0246 .062
CML -.023 .0215 .0216 .098 .011 .0255 .0250 .074 .065 .0158 .0155 .449
EB .001 .0253 .0251 .063 .011 .0255 .0250 .074 .016 .0274 .0274 .101
EB1 .013 .0248 .0245 .077 .006 .0255 .0251 .066 .005 .0256 .0249 .065
EB2 .012 .0257 .0252 .078 .006 .0256 .0251 .067 .007 .0272 .0271 .078
EB3 .012 .0247 .0252 .078 .006 .0255 .0252 .067 .007 .0253 .0269 .077
EB4 .012 .0247 .0252 .078 .006 .0255 .0252 .067 .007 .0253 .0269 .077
META BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .012 .0252 .0247 .075 .005 .0258 .0252 .066 .004 .0263 .0258 .068
UML .013 .0247 .0243 .075 .005 .0255 .0251 .065 .003 .0253 .0246 .061
CML -.023 .0215 .0215 .100 .011 .0255 .0249 .074 .065 .0158 .0155 .450
EB -.017 .0226 .0223 .077 .010 .0255 .0249 .072 .041 .0211 .0216 .216
EB1 .012 .0248 .0244 .074 .005 .0255 .0251 .065 .004 .0256 .0249 .063
EB2 .009 .0246 .0263 .077 .005 .0255 .0252 .066 .009 .0249 .0304 .101
EB3 .010 .0245 .0257 .076 .005 .0255 .0252 .066 .008 .0249 .0288 .089
EB4 .010 .0245 .0259 .076 .005 .0255 .0252 .066 .008 .0247 .0294 .093
✓k =  .5 for all k Main Effect of E Main Effect of G GxE Interaction
IPD BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .006 .0195 .0193 .041 .004 .0314 .0323 .106 .004 .0358 .0348 .123
UML .006 .0194 .0193 .041 .003 .0313 .0321 .104 .002 .0352 .0339 .115
CML .096 .0185 .0185 .960 -.049 .0304 .0312 .340 -.331 .0223 .0224 11.034
EB .010 .0195 .0194 .048 -.010 .0317 .0325 .116 .003 .0360 .0350 .123
EB1 .006 .0194 .0193 .041 .003 .0313 .0321 .104 .002 .0352 .0339 .115
EB2 .006 .0194 .0193 .041 .003 .0313 .0321 .104 .002 .0352 .0339 .115
EB3 .006 .0194 .0193 .041 .003 .0313 .0321 .104 .002 .0352 .0339 .115
EB4 .006 .0194 .0193 .041 .003 .0313 .0321 .104 .002 .0352 .0339 .115
META BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .005 .0195 .0193 .040 .001 .0315 .0321 .103 .001 .0360 .0345 .119
UML .005 .0195 .0192 .040 .001 .0313 .0319 .102 .001 .0353 .0338 .114
CML .095 .0186 .0185 .943 -.048 .0305 .0310 .330 -.329 .0223 .0224 10.858
EB .034 .0197 .0197 .153 -.040 .0310 .0315 .258 -.033 .0377 .0366 .241
EB1 .005 .0195 .0192 .040 .001 .0313 .0319 .102 .000 .0353 .0338 .114
EB2 .005 .0195 .0192 .040 .001 .0313 .0319 .102 .000 .0353 .0338 .114
EB3 .005 .0195 .0192 .040 .001 .0313 .0319 .102 .000 .0352 .0338 .114
EB4 .005 .0195 .0192 .040 .001 .0313 .0319 .102 .000 .0352 .0338 .114
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Table 3. Bias (BIAS), estimated standard errors (SE1), empirical standard errors (SE2) and 100⇥MSE (MSE) of b E ,b G and b GE resulting from standard logistic regression, unconstrained maximum likelihood, constrained maximum
likelihood, empirical Bayes and our proposed multi-study empirical Bayes estimators in both IPD and summary statistic
meta-analysis (META) simulation settings when G-E independence is violated. In the meta-analysis setting, we use the
inverse variance-covariance weighted approach to obtain the standard logistic, unconstrained, constrained and empirical
Bayes results.
✓k
iid⇠ N(.2, .12) Main Effect of E Main Effect of G GxE Interaction
IPD BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .015 .0269 .0268 .094 .009 .0253 .0247 .069 .006 .0254 .0253 .067
UML .017 .0264 .0265 .099 .008 .0251 .0244 .066 .003 .0245 .0241 .059
CML -.074 .0226 .0293 .629 .020 .0250 .0245 .102 .137 .0156 .0272 1.949
EB .007 .0275 .0273 .080 .018 .0251 .0245 .092 .011 .0260 .0260 .079
EB1 .017 .0264 .0265 .098 .008 .0251 .0244 .066 .004 .0246 .0241 .060
EB2 .017 .0264 .0265 .098 .008 .0251 .0244 .066 .004 .0246 .0242 .060
EB3 .017 .0264 .0265 .098 .008 .0251 .0244 .066 .004 .0245 .0242 .060
EB4 .017 .0264 .0265 .098 .008 .0251 .0244 .066 .004 .0245 .0242 .060
META BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .014 .0270 .0266 .091 .007 .0253 .0246 .066 .004 .0255 .0251 .064
UML .016 .0264 .0264 .094 .007 .0251 .0243 .064 .002 .0246 .0241 .059
CML -.072 .0226 .0290 .609 .020 .0250 .0245 .102 .136 .0157 .0269 1.928
EB -.023 .0255 .0270 .124 .019 .0250 .0244 .095 .038 .0236 .0275 .218
EB1 .015 .0264 .0264 .093 .007 .0251 .0243 .064 .003 .0246 .0241 .059
EB2 .015 .0265 .0264 .093 .007 .0251 .0243 .064 .003 .0246 .0242 .059
EB3 .015 .0264 .0264 .093 .007 .0251 .0243 .064 .003 .0245 .0242 .059
EB4 .015 .0264 .0264 .093 .007 .0251 .0243 .064 .003 .0245 .0242 .059
✓k
iid⇠ Unif( .2, .2) Main Effect of E Main Effect of G GxE Interaction
IPD BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .011 .0236 .0234 .066 .007 .0263 .0258 .071 .006 .0269 .0262 .072
UML .012 .0233 .0233 .068 .006 .0261 .0255 .068 .004 .0260 .0255 .066
CML .011 .0207 .0248 .074 .006 .0261 .0255 .069 .003 .0163 .0300 .091
EB .011 .0219 .0227 .063 .006 .0261 .0255 .069 .005 .0235 .0239 .059
EB1 .012 .0232 .0231 .068 .006 .0261 .0254 .068 .003 .0256 .0250 .064
EB2 .012 .0232 .0231 .067 .006 .0261 .0254 .068 .003 .0255 .0250 .063
EB3 .012 .0231 .0231 .067 .006 .0261 .0254 .068 .003 .0254 .0249 .063
EB4 .012 .0231 .0231 .067 .006 .0261 .0254 .068 .003 .0254 .0249 .063
META BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE BIAS SE1 SE2 MSE
LOG .010 .0236 .0232 .063 .005 .0264 .0257 .068 .004 .0270 .0260 .069
UML .011 .0233 .0231 .065 .005 .0262 .0254 .067 .003 .0261 .0254 .065
CML .011 .0208 .0246 .073 .007 .0261 .0255 .070 .005 .0164 .0297 .090
EB .012 .0216 .0237 .071 .005 .0261 .0254 .067 .002 .0222 .0276 .077
EB1 .011 .0232 .0230 .065 .005 .0262 .0254 .067 .003 .0256 .0248 .062
EB2 .011 .0232 .0229 .066 .006 .0262 .0254 .068 .003 .0252 .0247 .062
EB3 .012 .0231 .0229 .066 .005 .0262 .0254 .068 .002 .0250 .0247 .061
EB4 .012 .0231 .0229 .066 .005 .0262 .0254 .068 .002 .0250 .0247 .061
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Table 4. Summary statistics of age, BMI, sex and MAF (SNPs rs11642841, rs6499640 and rs1121980) stratified by cohort
and T2D disease status in six case-control data sets sampled from D2D2007 (1), DIAGEN (2), FUSION S2 (3), HUNT
(4), METSIM (5) and TROMSO (6). Age values are measured in years and BMI values are measured in kg/m2. SNP
effect estimates and p-values are reported for the following trend tests. aAge is regressed on SNP rs11642841 (0,1 or 2)
controlling for BMI and sex; bBMI is regressed on SNP rs6499640 (0,1 or 2) controlling for age and sex; cBMI is regressed
on SNP rs1121980 (0,1 or 2) controlling for age and sex.
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Table 5.Meta-analysis results of GEI (SNP1 ⇥ age, SNP2 ⇥ BMI and SNP3 ⇥ BMI) for the six case-control data sets
sampled from D2D2007, DIAGEN, FUSION S2, HUNT, METSIM and TROMSO controlling for BMI, age and sex
resulting from a standard logistic regression models. SNPs are abbreviated as SNP1 = rs11642841, SNP2 = rs6499640
and SNP3 = rs1121980. Estimates shown are inverse-variance weighted averages across all studies.
Univariate Multivariate
G⇥ E Model Estimate SE p-value Estimate SE p-value
SNP1 LOG -0.0009 0.0034 8.0⇥ 10 1 -0.0029 0.0033 3.8⇥ 10 1
⇥ age UML -0.0009 0.0034 8.0⇥ 10 1 -0.0023 0.0030 4.4⇥ 10 1
CML -0.0011 0.0030 7.1⇥ 10 1 -0.0030 0.0023 1.8⇥ 10 1
EB -0.0011 0.0032 7.4⇥ 10 1 -0.0028 0.0028 3.1⇥ 10 1
EB1 -0.0028 0.0026 2.7⇥ 10 1
EB2 -0.0030 0.0023 1.8⇥ 10 1
EB3 -0.0030 0.0023 1.9⇥ 10 1
EB4 -0.0030 0.0023 1.8⇥ 10 1
SNP2 LOG 0.0241 0.0084 4.1⇥ 10 3 0.0209 0.0083 1.1⇥ 10 2
⇥ BMI UML 0.0241 0.0084 4.1⇥ 10 3 0.0182 0.0067 6.5⇥ 10 3
CML 0.0174 0.0068 1.1⇥ 10 2 0.0024 0.0041 5.6⇥ 10 1
EB 0.0179 0.0076 1.9⇥ 10 2 0.0050 0.0050 3.2⇥ 10 1
EB1 0.0178 0.0068 8.9⇥ 10 3
EB2 0.0167 0.0070 1.7⇥ 10 2
EB3 0.0174 0.0069 1.1⇥ 10 2
EB4 0.0174 0.0069 1.2⇥ 10 2
SNP3 LOG 0.0007 0.0082 9.3⇥ 10 1 0.0014 0.0080 8.6⇥ 10 1
⇥ BMI UML 0.0007 0.0082 9.3⇥ 10 1 0.0035 0.0066 5.9⇥ 10 1
CML 0.0046 0.0067 5.0⇥ 10 1 0.0152 0.0041 1.8⇥ 10 4
EB 0.0026 0.0071 7.1⇥ 10 1 0.0065 0.0062 3.0⇥ 10 1
EB1 0.0041 0.0068 5.5⇥ 10 1
EB2 0.0152 0.0041 1.8⇥ 10 4
EB3 0.0152 0.0041 1.8⇥ 10 4
EB4 0.0152 0.0041 1.8⇥ 10 4
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Table 6. IPD results of GEI (SNP1 ⇥ age, SNP2 ⇥ BMI and SNP3 ⇥ BMI) for the six case-control data sets sampled
from D2D2007, DIAGEN, FUSION S2, HUNT,METSIM and TROMSO controlling for BMI, age, sex and study resulting
from our proposed methods. SNPs are abbreviated as SNP1 = rs11642841, SNP2 = rs6499640 and SNP3 = rs1121980.
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